Melanoma – (locally advanced or metastatic) | XPORT-MEL-033
Indication: Melanoma
Title: Safety and Efficacy of Selinexor in Combination with Pembrolizumab in Recurrent Advanced Melanoma
Drug: Selinexor
Please visit clinicaltrials.gov to learn more about this trial
Early Stage | Mid Stage | Late Stage | Commercial |
---|---|---|---|
Early Stage | Mid Stage | Late Stage | Commercial |